Bring your drug delivery devices to life faster and with less risk with our integrated end-to-end capabilities. From design and development to manufacturing and distribution, we work with large to small pharma companies or innovators and generics/biosilimars to produce hundreds of millions of successful drug delivery devices every year that improve people’s lives. We cover all the steps — even at the molecular stage — to take your drug delivery device from an idea to a complex, regulated drug delivery device.
Our product strategy services support your go-to-market tactics and all the developmental aspects of the product, as well as assess all risks attached to the development and launch.
- Device strategy
- Drug/device interaction
- Drug handling
- Drug filling/primary packaging
When designing, we ensure the most appropriate, commercially scalable and high-quality delivery device design for your drug. We choose the right technologies and apply usability and human-factors engineering to cover all elements of a high-performing drug delivery device.
- Device design and development
- Focus on convenience and human factors
- Reduce risk while maximizing investment dollars
With dedicated resources and facilities for manufacturing development, we can get you ready for clinical or commercial manufacturing faster and with lower risk.
- Clinical manufacturing
- Scale production
- Quality and regulatory
- Bulk packaging/shipping
Phillips-Medisize offers legal manufacturing, post-market surveillance services, and other extended capabilities to get your product to market quickly and safely.
- Drug and device assembly
- Combination products (pens, autoinjectors, inhalers, etc.)
- Unit packaging
- Handling and storage
- Distribution (multi-channel, multi-geo)
Drug Delivery Devices
A breakthrough in autoinjector innovation, the small, easy-to-use Aria combines reusable and disposable components along with full connectivity and digital patient guidance to improve patient care and comfort. The Aria platform offers customizable, differentiated performance at an attractive price — while reducing environmental impact.
Working with Phillips-Medisize on creating your connected health system enables related diagnosis and medication adherence, and helps instruct patients on treatment information and administration of medication.
We have a number of different technology platforms specially developed to support the design of connected devices. Our demonstrated feasibility enables low-cost embedded connectivity that ensures secure and reliable data transfer between a device and a digital interface.
Connected Health Platform
The Phillips-Medisize Connected Health Platform encompasses extensive information sharing, analytics capabilities, robust cybersecurity and streamlined regulatory documentation. It provides a unique opportunity to reduce risk, cost and time to market for connected health solutions.
Extensive quality management processes and regulatory certifications reduce risk and increase peace of mind.
- Rigorous ISO9001, ITAR, and TS16949 controls
- Integrated medical certifications and regulatory standards compliances
- Medical regulation and certification in the U.S., EU, Japan, China, and Canada
Phillips-Medisize is proud to be recognized for our innovation and dedication to driving the pharmaceutical industry forward.
Pharma Innovation Awards
- Best Innovation in Drug Delivery, Pharmapack Awards 2019
- Best Overall Connected Health Solution, Medtech Speak through
- Excellence in Pharma Drug Delivery Devices, CPhl Pharma Awards